Background Operative vaginal deliveries (OVD) are vaginal deliveries accomplished with the use of a vacuum device or forceps. If it is technically feasible and can be safely accomplished, termination of second stage labor by operative vaginal delivery is indicated in any condition threatening the mother or fetus that is likely to be relieved by delivery. Hence, the objective of this study is to assess the prevalence, common indication, outcome, and associated factors of operative vaginal delivery among mothers who gave birth in Jimma University Medical Center (JUMC). Method A facility-based cross-sectional study design was used in maternity ward on 242 mothers who gave birth by operative vaginal delivery from December 01, 2016, to May 30, 2017. The clinical data were collected using a check list, recordings of intrapartum fetal and maternal state, and immediate fetomaternal outcomes. The study participants were recruited using consecutive sampling method. Sociodemographics and related data were collected at exit using structured interviewer administered questionnaire which was developed by reviewing different literature and the remaining information abstracted from patient charts. Data were entered to Epidata 3.1 and exported to SPSS version 21 for analysis. Bivariate analysis was done to identify candidate variables using p<0.25. Multivariable logistic regression was used to control the effect of confounding variables and to identify factors affecting the fetomaternal outcome. Statistical significance was declared at P<0.05 using adjusted OR with 95% CI. Result Out of the 2348 pregnant mothers who gave birth in the labor ward of JUMC during the 6 months of the study period, 242 (10.3%) were by operative vaginal delivery (OVD). The commonest indication for operative vaginal delivery is found to be nonreassuring fetal heart rate pattern, 136 (56.2%). Out of all neonates delivered by operative vaginal delivery 210 (86.8%) had favorable outcome. Of all mothers who gave birth by operative vaginal delivery 232 (95.9%) had favorable outcome. Type of instrument used for operative vaginal delivery (AOR=0.228, 95%CI: 0.078, 0.671) and presence of grade two (AOR=0.163, 95%CI: 0.031, 0.858) and grade three (AOR=0.088,95%CI: 0.024,0.327) meconium stained amniotic fluid are factors affecting neonatal outcome while neonatal birth weight (AOR=0.007, 95%CI: 0.000, 0.151) is factor affecting maternal outcome of operative vaginal delivery. Conclusion Prevalence of operative vaginal delivery is found to be 10.3% with the commonest indication of nonreassuring fetal heart rate pattern. Nearly all of mothers and neonates had favorable outcome. Type of instrument applied for operative vaginal delivery is the strongest predictor of neonatal outcome while neonatal birth weight is the only predictor of maternal outcome identified in this study.
Background. Although the vast majority of abortions are performed in the first trimester, still 10–15% of terminations of pregnancies have taken place in the second trimester globally. As compared to first trimester, second trimester abortions disproportionately contribute to maternal morbidity and mortality especially in low-income countries where access to safe second trimester abortion is limited. The objective of this study was to identify factors affecting and outcome of induced safe second trimester medical abortion in Jimma University medical center, Southwest Ethiopia. Methods. Institution based cross-sectional study design was used to conduct a study among women who seek safe second trimester medical abortion services and admitted at gynecology ward. All (201) eligible study subjects included were those who came for safe medical abortion service during data collection period. Data collected using pretested structured questionnaire through exit-interviewing and some clinical data abstracted from their chart. The data was entered into EpData version 3.1 then exported to SPSS version 21.0 for analysis. Variables with P-value less than 0.25 in bivariate analysis were entered into the final predictive model. Multivariable logistic regression was used to identify determinants with 95% CI and P-value < 0.05. Hosmer and Lemeshow test were used to check model fitness at P-value of 0.05. Ethical clearance was obtained and confidentiality kept using codes and patient’s chart number. Results. In this study the response rate was 98.1%. Out of 201 women who participated in the study and were addmitted for safe second trimester medical abortion, 154 (76.6%) of them had complete abortion without any complication while the remaining 47 (23.4%) had incomplete abortion with one or more complication. Previous experience of abortion [AOR= 6.00, 95% CI= (3.77, 8.88)], gestational age [AOR=0.90, 95% CI= (0.07, 0.99)], parity [AOR=2.38, 95% CI= (1.04, 3.69)], cervical status [AOR=8.00, 95% CI= (5.72, 10.02)], overall waiting time for more than two weeks [AOR=0.53, 95% CI= (0.50, 0.96)], overall waiting time for two weeks [AOR=0.05, 95% CI= (0.01, 0.45)], and moderate anemia -(Hgb:7-10g/dl)-[AOR=0.07,95% CI= (0.01, 0.16)] were independent predictors for outcome of safe second trimester medical abortion. Conclusion. This finding implied that proportion of complete abortion without any complication overweighs incomplete abortions with one or more complication through induced safe second trimester medical abortion method. The outcome is strongly determined by gestational age, cervical status, previous experience of abortion, parity, moderate anemia, and overall waiting time. Induced second trimester medical abortion is already known as an effective and safe method. However, much should be done to reduce proportion of incomplete abortions by minimizing overall waiting time through intervening at low gestational age. Therefore, it is recommended that safe second trimester medical abortion services should be continued under a certain legal circumstances so as to reduce maternal morbidity and mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.